Product logins

Find logins to all Clarivate products below.


Vascular Access Devices – Market Insights – Asia Pacific (Supplemental)

Over the forecast period, the Asia Pacific vascular access device market will grow moderately through 2030, driven by an expanding patient population and increasing adoption of premium-priced devices. Importantly, vascular access devices represent a key component of care for COVID-19 patients, and therefore the pandemic’s impact on procedure volumes, unit sales, and revenues has been incorporated into market projections.

This Medtech 360 Report provides high-level market metrics for vascular access device market in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region, across a 11-year period.

Table of contents


Related Medtech Insights Reports

Report
Heart Valve Devices – Market Insights – Europe
The European heart valve device market will continue to observe moderate growth, particularly due to growing demand for minimally invasive cardiac interventions boosting the adoption of THV devices…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – United States
The US EP mapping and ablation device market will experience strong growth through 2034, driven by the rapid expansion of AF ablation procedures and the coinciding uptake of PFA devices, which…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Asia Pacific
The Asia Pacific EP mapping and ablation device market will experience strong growth through 2034, driven by rising procedure volumes, new product launches, increasing prevalence of cardiac…
Report
Aortic Repair Devices – Market Insights – United States
The US aortic repair device market will grow moderately during upcoming years, driven by the uptake of innovative stent grafts and the positive clinical evidence that supports their adoption. The…
Report
Interventional Oncology Devices – Market Insights – Asia Pacific
The Asia Pacific interventional oncology device market will see strong growth through 2034, driven by updated clinical guidelines, broader access to minimally invasive cancer treatments, and…